86 related articles for article (PubMed ID: 16730055)
1. Influence of department volume on cancer survival for gynaecological cancers--a population-based study in Tyrol, Austria.
Oberaigner W; Stühlinger W
Gynecol Oncol; 2006 Nov; 103(2):527-34. PubMed ID: 16730055
[TBL] [Abstract][Full Text] [Related]
2. Are survival rates for Tyrol published in the Eurocare studies biased?
Oberaigner W; Siebert U
Acta Oncol; 2009; 48(7):984-91. PubMed ID: 19714522
[TBL] [Abstract][Full Text] [Related]
3. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
4. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
[TBL] [Abstract][Full Text] [Related]
5. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
6. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in the diagnostic work-up of cancer patients in an internal medicine department: does age matter?
Domingo E; Suriñach JM; Murillo J; Duran M; Suriñach J; Baselga J; de Sevilla TF
Int J Clin Pract; 2008 Nov; 62(11):1723-9. PubMed ID: 19143858
[TBL] [Abstract][Full Text] [Related]
8. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
9. Influence of inflammatory polyarthritis on cancer incidence and survival: results from a community-based prospective study.
Franklin J; Lunt M; Bunn D; Symmons D; Silman A
Arthritis Rheum; 2007 Mar; 56(3):790-8. PubMed ID: 17328051
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
11. Surgical volume influences survival in patients undergoing resections for stage II colon cancers.
Morris M; Platell CF
ANZ J Surg; 2007 Oct; 77(10):902-6. PubMed ID: 17803560
[TBL] [Abstract][Full Text] [Related]
12. Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality.
Bartsch G; Horninger W; Klocker H; Pelzer A; Bektic J; Oberaigner W; Schennach H; Schäfer G; Frauscher F; Boniol M; Severi G; Robertson C; Boyle P;
BJU Int; 2008 Apr; 101(7):809-16. PubMed ID: 18321314
[TBL] [Abstract][Full Text] [Related]
13. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.
Trivers KF; Gammon MD; Abrahamson PE; Lund MJ; Flagg EW; Moorman PG; Kaufman JS; Cai J; Porter PL; Brinton LA; Eley JW; Coates RJ
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1822-7. PubMed ID: 17855700
[TBL] [Abstract][Full Text] [Related]
15. Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing.
Oberaigner W; Horninger W; Klocker H; Schönitzer D; Stühlinger W; Bartsch G
Am J Epidemiol; 2006 Aug; 164(4):376-84. PubMed ID: 16829552
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study.
Berretta M; Cappellani A; Di Benedetto F; Lleshi A; Talamini R; Canzonieri V; Zanet E; Bearz A; Nasti G; Lacchin T; Berretta S; Fisichella R; Balestreri L; Torresin A; Izzi I; Ortolani P; Tirelli U
Onkologie; 2009 Jun; 32(6):319-24. PubMed ID: 19521118
[TBL] [Abstract][Full Text] [Related]
17. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
[TBL] [Abstract][Full Text] [Related]
18. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
Hannibal CG; Cortes R; Engholm G; Kjaer SK
Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
20. Survival after breast cancer treatment: the impact of provider volume.
Bailie K; Dobie I; Kirk S; Donnelly M
J Eval Clin Pract; 2007 Oct; 13(5):749-57. PubMed ID: 17824868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]